I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
It is used as an active pharmaceutical intermediate.
Y C Chui, et al. Studies on the pharmacokinetics and metabolism of 4-chlorodiphenyl ether in rats.Drug Metab Dispos.198715(1), 44-50.
Livia A. Enache, et al. Development of a Scalable Synthetic Process for DG-051B, A First-in-Class Inhibitior of LTA4H.Org. Process Res. Dev.,200913(6), 1177-1184.
Hazard Statements: H315-H319-H335-H351
Causes skin irritation. Causes serious eye irritation. May cause respiratory irritation. Suspected of causing cancer.
Precautionary Statements: P201-P202-P261-P264b-P271-P280i-P281-P302+P352-P304+P340-P305+P351+P338-P308+P313-P332+P313-P337+P313-P362-P501c
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Avoid breathing dust/fume/gas/mist/vapours/spray. Wash face, hands and any exposed skin thoroughly after handling Use only outdoors or in a well-ventilated area. Wear eye/face protection. Use personal protective equipment as required. IF ON SKIN: Wash with plenty of soap and water. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. IF exposed or concerned: Get medical advice/attention. If skin irritation occurs: If eye irritation persists: Take off contaminated clothing and wash before reuse. Dispose of contents/ container to an approved waste disposal plant